{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-138973","form_type":"8-K","ticker":"TCRX","cik":"0001783328","company_name":"TScan Therapeutics, Inc.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.897746+00:00","generated_at":"2026-05-15T07:51:50.867961+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"TScan Therapeutics VP of Finance resigns; CFO Amello named principal accounting officer","bullets":["Leiden Dworak resigns as VP of Finance and principal accounting officer, effective April 10, 2026.","No disagreements between Dworak and TScan regarding operations, policies, or practices.","CFO Jason A. Amello appointed as principal accounting officer, effective same date.","Amello receives no additional compensation for assuming the principal accounting officer role.","Amello's background is incorporated by reference from TScan's May 2025 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-138973","json":"https://secwatch.observer/filing/0001193125-26-138973.json","markdown":"https://secwatch.observer/filing/0001193125-26-138973.md","text":"https://secwatch.observer/filing/0001193125-26-138973.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526138973/0001193125-26-138973-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526138973/d923169d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:51:50.867961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}